SCHEDULE 13G/A

Trevi Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 89532M101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Venrock Healthcare Capital Partners II, L.P.

  Shares: 1,266,457.00 · Class: 1.4%

• VHCP Co-Investment Holdings II, LLC

  Shares: 1,266,457.00 · Class: 1.4%

• VHCP Management II, LLC

  Shares: 1,266,457.00 · Class: 1.4%

• Venrock Healthcare Capital Partners III, L.P.

  Shares: 1,266,457.00 · Class: 1.4%

• VHCP Co-Investment Holdings III, LLC

  Shares: 1,266,457.00 · Class: 1.4%

• Venrock Healthcare Capital Partners EG, L.P.

  Shares: 1,266,457.00 · Class: 1.4%

• VHCP Management III, LLC

  Shares: 1,266,457.00 · Class: 1.4%

• VHCP Management EG, LLC

  Shares: 1,266,457.00 · Class: 1.4%

• Nimish Shah

  Shares: 1,266,457.00 · Class: 1.4%

• Bong Y Koh

  Shares: 1,266,457.00 · Class: 1.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.